Almirall LLC v. Taro Pharm. Indus. Ltd.

Core Citations

OVERRULES OTHER CASE

• Loctite Corp. v. Ultraseal Ltd.

This document cites

• Federal Cases - KSR Int'l Co. v. Teleflex Inc.
• Federal Cases - Momenta Pharms., Inc. v. Amphastar Pharms., Inc.
• Federal Cases - Calhoun v. Yamaha Motor Corp., U.S.A.
• Federal Cases - Stumbo v. Eastman Outdoors, Inc.
• Federal Cases - Builders Steel Co. v. Commissioner of Internal Rev.



See all quotations

• Federal Cases - Walzer v. St. Joseph State Hospital, 00-1177EM
• Federal Cases - First American State Bank v. Continental Ins. Co.
• Federal Cases - Glaxo Group Ltd. v. TorPharm, Inc., 97-1556
• Federal Cases - 141 Ltd. P'ship And v. Microsoft Corp.
• Federal Cases - Egyptian Goddess, Inc. v. Swisa, Inc.
• Federal Cases - Eurand, Inc. v. Mylan Pharms. Inc. (In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litig.), Appeal No. 2011-1399
• Federal Cases - Glaxo, Inc. v. Novopharm, Ltd.
• Federal Cases - Depuy Spine, Inc. v. Medtronic Sofamor Danek, Inc.
• Federal Cases - Pineda v. Ford Motor Co.
• Federal Cases - Easley v. Anheuser-Busch, Inc.
• Federal Cases - High Point Design LLC v. Buyers Direct, Inc.
• Federal Cases - Ethicon Endo-Surgery, Inc. v. U.S. Surgical Corp.
• Federal Cases - Leonard v. Stemtech Health Scis., Inc.
• Federal Cases - Glaxo Group Ltd v. Ranbaxy Pharmaceuticals
• Federal Cases - Dystar Textilfarben Gmbh & Co. v. C.H. Patrick
• Federal Cases - Fields Engineering & Equipment, Inc. v. Cargill, Inc.
• Federal Cases - Graver Tank Mfg Co v. Linde Air Products Co
• Federal Cases - Abraxis Bioscience, Inc. v. Mayne Pharma (Usa)
• Federal Cases - Nobelpharma AB v. Implant Innovations, Inc.
• Federal Cases - Loctite Corp. v. Ultraseal Ltd.
• Federal Cases - Microsoft Corp. v. i4i Ltd. P'ship
• Federal Cases - Daubert v. Merrell Dow Pharmaceuticals, Inc
• Federal Cases - Intendis GMBH v. Glenmark Pharm. Inc.
• Federal Cases - Elcock v. Kmart Corp.
• US - Reference Stubs - Infringement of patent
• US - Reference Stubs - Conditions for patentability; non-obvious subject matter
• US - Reference Stubs - New drugs
• US - Reference Stubs - Claim for Relief Arising under 35 U.S.C. Section 271(e)(2) or 42 U.S.C. Section 262